Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s

Jennifer J. Kiser,Darlene Lu,Susan L. Rosenkranz,Gene D. Morse,Robin DiFrancesco,Kenneth E. Sherman,Adeel A. Butt

Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309s

2017

Jennifer J. Kiser
Darlene Lu
Susan L. Rosenkranz
Gene D. Morse
Robin DiFrancesco
Kenneth E. Sherman
Adeel A. Butt

Objective The objective of this study was to determine the magnitude of drug interactions between the hepatitis C virus (HCV) protease inhibitor boceprevir (BOC) and antiretroviral (ARV) agents in persons with HIV/HCV co-infection.

Keywords:

Clinical trial
Pharmacology
Hepatitis C virus
Medicine
Virology
Boceprevir
Pharmacokinetics
Hepatitis C
HIV/AIDS
Drug
Pharmacotherapy
Hepacivirus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations